title: Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.
abstract: Since the human immunodeficiency virus (HIV-1) is transmitted either parenterally or sexually, both mucosal and systemic immune responses may be required to provide protective immunity. Attenuated Salmonella vectors expressing heterologous antigen can stimulate responses in both compartments. To evaluate the utility of Salmonella vectors as an HIV-1 vector vaccine, a gene expression cassette encoding recombinant HIV-1 gp120 (rgp120) was integrated into the hisOGD locus of Salmonella typhimurium aroA strain, SL3261 (SL3261::120). To test if increased antigen expression potentiates immunogenicity, strains were constructed that express rgp120 from a multicopy asd-stabilized plasmid (SL7207 pYA:120). Immunoblot analysis demonstrated that SL7207 pYA:120 expressed approximately 50-fold more rgp120 than SL3261::120. Oral immunization of BALB/c mice with these strains did not stimulate an env-specific CTL response or a significant rise in antigp120 antibody titer as compared to controls. However, splenic T cells from SL7207 pYA::120 immunized mice proliferated upon restimulation with gp120 in vitro while splenocytes from SL3261::120 immunized mice did not, gp120 restimulated splenic T cells from SL7207 pYA:120 immune mice also produced IFN-gamma but no IL-5. Two conclusions can be drawn from these results. First, high level expression of rgp120 in Salmonella vectors is necessary to stimulate a gp120-specific immune response in mice. Second, Salmonella::rgp120 stimulates a gp120-specific Th1 response in mice. This is the first report to describe the construction of a Salmonella::rgp120 vector vaccine that is immunogenic in mice.
authors.affiliation: Department of Geographic Medicine, School of Medicine, University of Maryland at Baltimore 21201, USA.
authors.forename: T R
authors.initials: TR
authors.lastname: Fouts
authors.forename: R G
authors.initials: RG
authors.lastname: Tuskan
authors.forename: S
authors.initials: S
authors.lastname: Chada
authors.forename: D M
authors.initials: DM
authors.lastname: Hone
authors.forename: G K
authors.initials: GK
authors.lastname: Lewis
mesh_terms: D016915:AIDS Vaccines / Q000235:genetics* / Q000276:immunology*; D000818:Animals; D001483:Base Sequence; D016207:Cytokines / Q000096:biosynthesis; D000939:Epitopes / Q000235:genetics; D015752:Genes, env / Q000276:immunology; D005822:Genetic Vectors / Q000276:immunology*; D015483:HIV Antibodies / Q000096:biosynthesis; D015699:HIV Envelope Protein gp120 / Q000235:genetics* / Q000276:immunology; D015497:HIV-1 / Q000235:genetics / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D015202:Protein Engineering; D012486:Salmonella typhimurium / Q000235:genetics* / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D018417:Th1 Cells / Q000378:metabolism; D014614:Vaccines, Synthetic / Q000235:genetics* / Q000276:immunology*
chemical_list: D016915:AIDS Vaccines; D016207:Cytokines; D000939:Epitopes; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D014614:Vaccines, Synthetic